MIR-138-5P inhibits the progression of prostate cancer by targeting FOXC1

被引:27
作者
Huang, Hui [1 ]
Xiong, Ying [2 ]
Wu, Zhensheng [1 ]
He, Yuhui [1 ]
Gao, Xianglin [1 ]
Zhou, Zhangyan [2 ]
Wang, Tao [1 ]
机构
[1] Guangzhou Med Univ, Affiliated Shunde Hosp, Dept Urol, A163 Lecong Ave, Foshan, Guangdong, Peoples R China
[2] Yangtze Univ, Affiliated Hosp 1, Dept Urol, Jingzhou, Peoples R China
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2020年 / 8卷 / 04期
关键词
FOXC1; MIR-138-5P; prostate cancer; tumor suppressor gene; MIGRATION; MICRORNA; INVASION;
D O I
10.1002/mgg3.1193
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Studies have suggested that micro-RNAs (miRNAs) can function as an oncogene or a tumor suppressor in cancers. However, the role of MIR-138-5P (613394) in prostate cancer (PCa) remains unclear. Methods Expression level of MIR-138-5P in PCa cell lines and normal cell line was analyzed with the quantitative real-time PCR method. Cell counting kit-8 assay, colony formation assay, wound-healing assay, and transwell invasion assay were performed to analyze the biological functions of MIR-138-5P. Results We showed MIR-138-5P expression level was significantly decreased in PCa cell lines compared with the normal cell line. Overexpression of MIR-138-5P inhibits PCa cell proliferation, colony formation, cell migration, and cell invasion in vitro. Mechanistically, we showed Forkhead box C1 (FOXC1, 601090) was a direct target for MIR-138-5P in PCa. We confirmed that overexpression of FOXC1 partially reversed the effects of MIR-138-5P on PCa cell behaviors. Conclusions Collectively, we showed that MIR-138-5P functions as a tumor suppressor gene in PCa via targeting FOXC1.
引用
收藏
页数:7
相关论文
共 19 条
  • [1] Acunzo Mario, 2015, Adv Biol Regul, V57, P1, DOI 10.1016/j.jbior.2014.09.013
  • [2] Prostate cancer
    Alonso Castillejos-Molina, Ricardo
    Bernardo Gabilondo-Navarro, Fernando
    [J]. SALUD PUBLICA DE MEXICO, 2016, 58 (02): : 279 - 284
  • [3] FOXC1 silencing inhibits the epithelial-to-mesenchymal transition of glioma cells: Involvement of -catenin signaling
    Cao, Qinchen
    Wang, Xinxin
    Shi, Yonggang
    Zhang, Mingzhi
    Yang, Jing
    Dong, Meilian
    Mi, Yin
    Zhang, Zhigang
    Liu, Ke
    Jiang, Li
    Wang, Na
    Wang, Ping
    [J]. MOLECULAR MEDICINE REPORTS, 2019, 19 (01) : 251 - 261
  • [4] MicroRNA-301a-3p overexpression promotes cell invasion and proliferation by targeting runt-related transcription factor 3 in prostate cancer
    Fan, Li
    Wang, Yao
    Huo, Wei
    Wang, Wei-Hua
    [J]. MOLECULAR MEDICINE REPORTS, 2019, 20 (04) : 3755 - 3763
  • [5] Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide
    Greene, John
    Baird, Anne-Marie
    Casey, Orla
    Brady, Lauren
    Blackshields, Gordon
    Lim, Marvin
    O'Brien, Odharnaith
    Gray, Steven G.
    McDermott, Raymond
    Finn, Stephen P.
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [6] Regulation of microRNA biogenesis
    Ha, Minju
    Kim, V. Narry
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2014, 15 (08) : 509 - 524
  • [7] FOXC1: an emerging marker and therapeutic target for cancer
    Han, B.
    Bhowmick, N.
    Qu, Y.
    Chung, S.
    Giuliano, A. E.
    Cui, X.
    [J]. ONCOGENE, 2017, 36 (28) : 3957 - 3963
  • [8] MicroRNAs in prostate cancer: Functional role as biomarkers
    Kanwal, Rajnee
    Plaga, Alexis R.
    Liu, Xiaoqi
    Shukla, Girish C.
    Gupta, Sanjay
    [J]. CANCER LETTERS, 2017, 407 : 9 - 20
  • [9] WNT signalling in prostate cancer
    Murillo-Garzon, Virginia
    Kypta, Robert
    [J]. NATURE REVIEWS UROLOGY, 2017, 14 (11) : 683 - 696
  • [10] The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25
    Nishimura, DY
    Swiderski, RE
    Alward, WLM
    Searby, CC
    Patil, SR
    Bennet, SR
    Kanis, AB
    Gastier, JM
    Stone, EM
    Sheffield, VC
    [J]. NATURE GENETICS, 1998, 19 (02) : 140 - 147